Mosnaim Giselle, Carrasquel Michelle, Ewing Tatum, Berty Alba, Snedden Madeline
Division of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA
Division of Allergy and Immunology, Department of Medicine, Endeavor Health, Evanston, IL, USA.
Eur Respir Rev. 2025 Mar 19;34(175). doi: 10.1183/16000617.0143-2024. Print 2025 Jan.
Poor adherence to maintenance inhalers and incorrect maintenance and reliever inhaler technique are associated with poor asthma outcomes. Remote therapeutic monitoring and remote patient monitoring support asthma guideline recommendations to regularly review adherence and inhaler technique, with the ultimate goal to improve asthma outcomes.
This work systematically reviewed all clinical trials testing remote monitoring interventions on asthma outcomes.
A systematic search of PubMed, SCOPUS, Ovid, CINAHL and reference review databases was conducted from 1 January 2000 to 30 April 2024. Articles were included if the title or abstract included MeSH terms of "nebulizers and vaporizers" in combination with "digital", "remote", "electronic" or "smart inhaler" to identify interventional studies testing remote monitoring for asthma. We characterised populations, interventions, control groups, outcomes, timeframe and setting across studies.
Of 2043 articles reviewed, 19 articles met the inclusion criteria (n=14 remote therapeutic monitoring; n=5 remote patient monitoring). While a wide range of outcomes were measured across studies, overall, the studies (n=19) that met the inclusion criteria demonstrated a slower decline in maintenance inhaler adherence (n=13), decreased reliever use (n=6) and improvements in asthma control (n=3). They did not demonstrate positive outcomes on asthma exacerbations and healthcare utilisation, but this may be due to study sample sizes, eligibility criteria and duration.
Remote monitoring demonstrates improvements in important intermediary asthma outcomes. Future studies with larger sample sizes, duration and requiring greater disease severity as eligibility criteria are warranted to evaluate their efficacy at decreasing asthma-related oral steroid use, emergency department visits, hospitalisations and costs.
维持性吸入器依从性差以及维持和缓解性吸入器使用技术不正确与哮喘预后不良相关。远程治疗监测和远程患者监测有助于支持哮喘指南中定期评估依从性和吸入器使用技术的建议,最终目标是改善哮喘预后。
本研究系统回顾了所有测试远程监测干预对哮喘预后影响的临床试验。
对2000年1月1日至2024年4月30日期间的PubMed、SCOPUS、Ovid、CINAHL和参考文献数据库进行了系统检索。如果文章标题或摘要中包含“雾化器和蒸发器”与“数字”“远程”“电子”或“智能吸入器”的医学主题词组合,以识别测试哮喘远程监测的干预性研究,则纳入这些文章。我们对各项研究中的人群、干预措施、对照组、结局、时间范围和研究背景进行了描述。
在检索的2043篇文章中,19篇符合纳入标准(14篇为远程治疗监测;5篇为远程患者监测)。虽然各项研究测量了广泛的结局,但总体而言,符合纳入标准的研究(共19项)显示维持性吸入器依从性下降减缓(13项研究)、缓解药物使用减少(6项研究)以及哮喘控制得到改善(3项研究)。这些研究未显示出对哮喘急性加重和医疗保健利用的积极影响,但这可能是由于研究样本量、纳入标准和研究持续时间所致。
远程监测显示出在重要的哮喘中间结局方面有所改善。未来有必要开展样本量更大、持续时间更长且以更严重疾病为纳入标准的研究,以评估其在减少哮喘相关口服类固醇使用、急诊就诊、住院和费用方面的疗效。